Protech Home Medical Announces Date and Time for Quarterly Conference Call
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN.
CINCINNATI, March 21, 2019 (GLOBE NEWSWIRE) -- Protech Home Medical Corp. (the “Company”) (TSX-V: PTQ), a healthcare services company with operations in the U.S., today announced that it will host its Quarterly Earnings and Corporate Update Conference Call on Tuesday, April 2nd, 2019 at 10:00 a.m. EDT.
Conference Call Details:
Tuesday, April 2nd, 2019 at 10:00 a.m. EDT.
Canada/US Toll Free: +1-800-319-4610
International: +1-604-638-5340
Please dial in 5-10 minutes before the call.
ABOUT PROTECH HOME MEDICAL
The Company provides in-home monitoring and disease management services for patients in the United States healthcare market. It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility and other chronic health conditions. The initial service line includes providing in-home monitoring equipment, supplies and services to patients in the U.S. who take prescription blood thinners, such as Coumadin® (warfarin).
The primary business objective of the Company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. The Company’s organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient’s services and making life easier for the patient.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information please visit our website at www.phmcompanies.com, or contact:
Greg Crawford
CEO/Chairman
Protech Home Medical Corp.
859-300-6455
investorinfo@myphm.com